Ramipril and Abnormal clotting factor - a phase IV clinical study of FDA data

Summary:

Abnormal clotting factor is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Clozaril, and have Schizophrenia.

The phase IV clinical study analyzes which people have Abnormal clotting factor when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Abnormal clotting factor?

Abnormal clotting factor is found to be associated with 42 drugs and 182 conditions by eHealthMe. Check the latest studies of Abnormal clotting factor.

On Jul, 06, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 14 people (0.01%) have Abnormal clotting factor.

Could Ramipril cause Abnormal clotting factor?

Among these 14 people:

How long have people been on Ramipril when they have Abnormal clotting factor? *

What is the gender of people who have Abnormal clotting factor when taking Ramipril? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Abnormal clotting factor when taking Ramipril? *

What are other drugs people take besides Ramipril? *

Clozaril: 12 people, 85.71%
Olanzapine: 11 people, 78.57%
Paracetamol: 10 people, 71.43%
Ibuprofen: 8 people, 57.14%
Tacrolimus: 1 person, 7.14%

What are other side effects people have besides Abnormal clotting factor? *

White Blood Cell Count Increased: 13 people, 92.86%
Overdose: 13 people, 92.86%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 13 people, 92.86%
Hepatic Function Abnormal: 13 people, 92.86%
Arrhythmias (irregular heartbeat): 13 people, 92.86%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.14%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 1 person, 7.14%
Disease Recurrence: 1 person, 7.14%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 12 people, 85.71%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Abnormal clotting factor?

- Check whether Abnormal clotting factor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abnormal clotting factor:

Abnormal clotting factor (42 drugs)

Browse all the conditions that are associated with Abnormal clotting factor:

Abnormal clotting factor (182 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.